High serum levels of galectin-1 observed in obesity, is a risk factor for developing T2D over time and is associated with poor outcome in several malignant cancers including prostate cancer and ovarian cancer [7, 9, 27–29]. Here, LGALS1 is linked to prostate carcinoma.